302 related articles for article (PubMed ID: 18421621)
1. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats.
Deng Y; Bi HC; Zhao LZ; He F; Liu YQ; Yu JJ; Ou ZM; Ding L; Chen X; Huang ZY; Huang M; Zhou SF
Xenobiotica; 2008 May; 38(5):465-81. PubMed ID: 18421621
[TBL] [Abstract][Full Text] [Related]
2. Induction of cytochrome P450 3A by the Ginkgo biloba extract and bilobalides in human and rat primary hepatocytes.
Deng Y; Bi HC; Zhao LZ; Wang XD; Chen J; Ou ZM; Ding L; Xu LJ; Guan S; Chen X; Zhou SF; Huang M
Drug Metab Lett; 2008 Jan; 2(1):60-6. PubMed ID: 19356072
[TBL] [Abstract][Full Text] [Related]
3. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
Chang TK; Chen J; Teng XW
Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent induction of hepatic cytochrome P450 enzyme activity and mRNA expression by bilobalide in rats.
Taki Y; Yamazaki Y; Shimura F; Yamada S; Umegaki K
J Pharmacol Sci; 2009 Mar; 109(3):459-62. PubMed ID: 19276617
[TBL] [Abstract][Full Text] [Related]
5. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
Kuo If; Chen J; Chang TK
Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
[TBL] [Abstract][Full Text] [Related]
6. Bilobalide in Ginkgo biloba extract is a major substance inducing hepatic CYPs.
Umegaki K; Taki Y; Endoh K; Taku K; Tanabe H; Shinozuka K; Sugiyama T
J Pharm Pharmacol; 2007 Jun; 59(6):871-7. PubMed ID: 17637180
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
Ahlemeyer B; Krieglstein J
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383
[TBL] [Abstract][Full Text] [Related]
8. Induction of propranolol metabolism by Ginkgo biloba extract EGb 761 in rats.
Zhao LZ; Huang M; Chen J; Ee PL; Chan E; Duan W; Guan YY; Hong YH; Chen X; Zhou S
Curr Drug Metab; 2006 Aug; 7(6):577-87. PubMed ID: 16918313
[TBL] [Abstract][Full Text] [Related]
9. Human pregnane X receptor agonism by Ginkgo biloba extract: assessment of the role of individual ginkgolides.
Lau AJ; Yang G; Rajaraman G; Baucom CC; Chang TK
J Pharmacol Exp Ther; 2010 Dec; 335(3):771-80. PubMed ID: 20739453
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats.
Suzuki R; Kohno H; Sugie S; Sasaki K; Yoshimura T; Wada K; Tanaka T
Cancer Lett; 2004 Jul; 210(2):159-69. PubMed ID: 15183531
[TBL] [Abstract][Full Text] [Related]
11. Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice.
Taki Y; Yokotani K; Yamada S; Shinozuka K; Kubota Y; Watanabe Y; Umegaki K
Phytomedicine; 2012 Jan; 19(2):177-82. PubMed ID: 21802929
[TBL] [Abstract][Full Text] [Related]
12. Effects of single intraperitoneal injections of an extract of Ginkgo biloba (EGb 761) and its terpene trilactone constituents on barbital-induced narcosis in the mouse.
Brochet D; Chermat R; DeFeudis FV; Drieu K
Gen Pharmacol; 1999 Sep; 33(3):249-56. PubMed ID: 10480658
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS.
Biber A; Koch E
Planta Med; 1999 Mar; 65(2):192-3. PubMed ID: 10193211
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
[TBL] [Abstract][Full Text] [Related]
15. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver.
Sasaki K; Hatta S; Wada K; Ueda N; Yoshimura T; Endo T; Sakata M; Tanaka T; Haga M
Life Sci; 2002 Feb; 70(14):1657-67. PubMed ID: 11991253
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a gas chromatographic-mass spectrometric method for simultaneous identification and quantification of marker compounds including bilobalide, ginkgolides and flavonoids in Ginkgo biloba L. extract and pharmaceutical preparations.
Deng F; Zito SW
J Chromatogr A; 2003 Jan; 986(1):121-7. PubMed ID: 12585329
[TBL] [Abstract][Full Text] [Related]
17. The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex.
Yoshitake T; Yoshitake S; Kehr J
Br J Pharmacol; 2010 Feb; 159(3):659-68. PubMed ID: 20105177
[TBL] [Abstract][Full Text] [Related]
18. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion.
Liebgott T; Miollan M; Berchadsky Y; Drieu K; Culcasi M; Pietri S
Basic Res Cardiol; 2000 Oct; 95(5):368-77. PubMed ID: 11099163
[TBL] [Abstract][Full Text] [Related]
19. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
Lau AJ; Chang TK
Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
